For: | Louis E, Belaiche J, Reenaers C. Are we giving biologics too much time? When should we stop treatment? World J Gastroenterol 2008; 14(36): 5528-5531 [PMID: 18810771 DOI: 10.3748/wjg.14.5528] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v14/i36/5528.htm |
Number | Citing Articles |
1 |
Catarina Frias Gomes, Jean-Frédéric Colombel, Joana Torres. De-escalation of Therapy in Inflammatory Bowel Disease. Current Gastroenterology Reports 2018; 20(8) doi: 10.1007/s11894-018-0643-8
|
2 |
Konstantinos Papamichael, Severine Vermeire. Withdrawal of anti-tumour necrosis factor α therapy in inflammatory bowel disease. World Journal of Gastroenterology 2015; 21(16): 4773-4778 doi: 10.3748/wjg.v21.i16.4773
|
3 |
Mi-Young Park, Geun Eog Ji, Mi-Kyung Sung. Dietary Kaempferol Suppresses Inflammation of Dextran Sulfate Sodium-Induced Colitis in Mice. Digestive Diseases and Sciences 2012; 57(2): 355 doi: 10.1007/s10620-011-1883-8
|
4 |
Sumathi Sankaran-Walters, Kanat Ransibrahmanakul, Irina Grishina, Jason Hung, Enrique Martinez, Thomas Prindiville, Satya Dandekar. Epstein–Barr virus replication linked to B cell proliferation in inflamed areas of colonic mucosa of patients with inflammatory bowel disease. Journal of Clinical Virology 2011; 50(1): 31 doi: 10.1016/j.jcv.2010.09.011
|